SCHEMBL253244

SCHEMBL253244

[O-][n+]1nncc2ccccc21

nearest known ligand 0.41

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
ATM Q13315 1/20 0.41
NPC1 O15118 1/20 0.34
RAB9A P51151 1/20 0.34
ACHE P22303 12/20 0.31
BCHE P06276 11/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL874077 0.72 CYP1A2 (0.38)
SCHEMBL51544 0.70 ATM (0.41) ATMNPC1RAB9A
Hydrochloric Acid SCHEMBL10501335 0.68 ATM (0.40) ATMNPC1RAB9AACHEBCHE
SCHEMBL5894390 0.67 ATM (0.43) ATMACHEBCHE
SCHEMBL7501877 0.65 ATM (0.69) ATMNPC1RAB9AACHE
SCHEMBL51581 0.65 ATM (0.41) ATMNPC1RAB9A
SCHEMBL9879567 0.65 KDM4E (0.34) ATM
SCHEMBL61984 0.65 ATM (0.41) ATMNPC1RAB9AACHE
SCHEMBL7337546 0.64 ATM (0.45) ATMNPC1RAB9AACHEBCHE
SCHEMBL7869230 0.64 ATM (0.40) ATMNPC1RAB9AACHEBCHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 721 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12532631-B2 Electronic apparatus and method of manufacturing the same SAMSUNG DISPLAY CO., LTD. (KR) 2026-01-20 US claimed
CN-119907692-A Isolated targeted delivery system for the treatment of gliomas 塞尔丽思股份公司 2025-04-29 CN claimed
US-12127426-B2 Heterocyclic compound and electronic apparatus SAMSUNG DISPLAY CO., LTD. (KR) 2024-10-22 US claimed
CN-114497728-B Electrolyte, electrochemical device and electronic device 宁德新能源科技有限公司 2024-06-11 CN claimed
CN-117987193-A Bentonite grease and preparation method thereof 中国石油化工股份有限公司 2024-05-07 CN claimed
CN-117965228-A Composite lithium-based lubricating grease and preparation method thereof 中国石油化工股份有限公司 2024-05-03 CN claimed
CN-117964612-A Benzotriazinone oxadiazole derivative and preparation method and application thereof 长江大学 2024-05-03 CN claimed
CN-117946792-A Hydraulic oil composition and preparation method thereof 中国石油化工股份有限公司 2024-04-30 CN claimed
CN-117917464-A Electric automobile lubricating oil composition and preparation method thereof 中国石油化工股份有限公司 2024-04-23 CN claimed
CN-117756732-A Benzotriazine derivative, and preparation method and application thereof 中国石油化工股份有限公司 2024-03-26 CN claimed
CN-1211919-A Radiosensitizing taxanes and their pharmaceutical preparations UNIV FLORIDA STATE (US) 1999-03-24 CN claimed
WO-1999009012-A1 PEROXIDE-BASED CHEMILUMINESCENT ASSAYS AND CHEMILUMINESCENT COMPOUNDS USED THEREIN MAINE MEDICAL CENTER (US) 1999-02-25 WO claimed
EP-0855909-A1 RADIOSENSITIZING TAXANES AND THEIR PHARMACEUTICAL PREPARATIONS FLORIDA STATE UNIVERSITY (US) 1998-08-05 EP claimed
WO-1997009979-A9 RADIOSENSITIZING TAXANES AND THEIR PHARMACEUTICAL PREPARATIONS 1997-06-05 WO claimed
WO-1997009979-A1 RADIOSENSITIZING TAXANES AND THEIR PHARMACEUTICAL PREPARATIONS FLORIDA STATE UNIVERSITY (US) 1997-03-20 WO claimed
US-5424268-A Imaging medium and process POLAROID CORPORATION (US) 1995-06-13 US claimed
EP-0259362-A1 PREPARATION OF 3-DIMETHYLAMINO-7-METHYL-1,2,4-BENZOTRIAZINE-1-OXIDE AND AZAPROPAZONE A.H. ROBINS COMPANY LIMITED (GB) 1988-03-16 EP claimed
EP-0259371-A1 PREPARATION OF 3-DIMETHYLAMINO-7-METHYL-1,2,4-BENZOTRIAZINE-1-OXIDE AND AZAPROPAZONE. ROBINS A H CO LTD (GB) 1988-03-16 EP claimed
WO-1987004432-A1 PREPARATION OF 3-DIMETHYLAMINO-7-METHYL-1,2,4-BENZOTRIAZINE-1-OXIDE AND AZAPROPAZONE A.H. ROBINS COMPANY LIMITED (GB) 1987-07-30 WO claimed
WO-1987004433-A1 PREPARATION OF 3-DIMETHYLAMINO-7-METHYL-1,2,4-BENZOTRIAZINE-1-OXIDE AND AZAPROPAZONE A.H. ROBINS COMPANY LIMITED (GB) 1987-07-30 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12127426-B2 Heterocyclic compound and electronic apparatus ERCC4, ERCC1, ESD ATM 3238/4885NPC1 2518/4885RAB9A 1011/4885
US-12532631-B2 Electronic apparatus and method of manufacturing the same SRMS, LRRK2, TEC ATM 347/4885NPC1 4201/4885RAB9A 396/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.